The effect of rIL-2/IFN-α immunotherapy on actuarial survival (A), DFS (B), and relapse (C) in NHL patients who received immunotherapy (n = 32) versus controls (n = 36, TRT + R) after autologous bone marrow transplantation (P < .01, P < .01, and P < .01, respectively).